Prestige Consumer Healthcare Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Prestige Consumer Healthcare Inc.'s yearly results (2023–2026), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Tangible Assets Ratio: Of every $100 the company owns, $18 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. Less tangible than 98% of Healthcare companies in United States.
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 26.2 times. Higher than 98% of Healthcare companies in United States.
- Debt Due Cover Ratio: Debt due within a year is covered 86.3 times by its yearly operating cash. Higher than 97% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$123Over the last 3 years, every $100 of reported profit came with $123 of operating cash.
Lower than 70% of Healthcare companies in United States.
Self-Funding Ratio
26.2×Over the last 3 years its own operating cash covered its investment spending (capex) 26.2 times.
Higher than 98% of Healthcare companies in United States.
Cash Locked Ratio
$30For every $100 of sales, $30 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $23 tied up three years earlier.
More money tied up than 66% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
1/3 · 2/3Sales grew in 1 of the last 3 years; profit grew in 2 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales barely changed
Sales changed by -3% in 3 years, too little to measure extra profit per extra sales.
Asset Productivity Ratio
-3% / +4%In 3 years sales changed by -3% while total assets changed by +4%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
86.3×Debt due within a year is covered 86.3 times by its yearly operating cash.
Higher than 97% of Healthcare companies in United States.
Cash Cushion Ratio
−42%Debt, after subtracting cash, equals 42% of its market value (net debt).
Lower than 91% of Healthcare companies in United States.
Tangible Assets Ratio
18%Of every $100 the company owns, $18 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 98% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 88% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Prestige Consumer Healthcare Inc. owes $0.58 for every $1 it owns. Net profit fell 11% in the year to Mar 2026.
Compared with Healthcare companies in United States · latest annual results Mar 2026.
P/E ratio
13.9Investors pay $13.9 for every $1 of Prestige Consumer Healthcare Inc.'s yearly profit, lower than 76% of Healthcare companies in United States.
P/B ratio
1.22The share price is 1.22 times Prestige Consumer Healthcare Inc.'s book value per share, lower than 75% of Healthcare companies in United States.
Market cap
$2.3 BThe total market value of all of Prestige Consumer Healthcare Inc.'s shares at today's price (share price × number of shares), larger than 77% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$1.9 BWhat Prestige Consumer Healthcare Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$40.46Net worth divided by the number of shares. The share price of $49.46 is 1.2 times this, which is the P/B above.
Return on equity (ROE)
9.1%Prestige Consumer Healthcare Inc. earned 9.1% on its shareholders' money over the last year, higher than 83% of Healthcare companies in United States.
Owes vs Owns
0.58×Prestige Consumer Healthcare Inc. owes $0.58 for every $1 it owns (moderate), higher than 62% of Healthcare companies in United States.
Dividend yield
NonePrestige Consumer Healthcare Inc. does not currently pay a dividend.
Revenue growth
-4%Revenue fell 4% in the year to Mar 2026, and shrank 1% a year on average over 3 years.
Profit growth
-11%Net profit fell 11% in the year to Mar 2026.
Profit margin
17.5%Prestige Consumer Healthcare Inc. keeps $17 of every $100 of revenue as net profit.
Cash quality
1.4×Cash from Prestige Consumer Healthcare Inc.'s business was 1.4× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
7.3×Prestige Consumer Healthcare Inc.'s operating profit covered its interest costs 7.3 times in the year to Mar 2026.
Cash vs debt
Net debtPrestige Consumer Healthcare Inc. had $982 M more debt than cash (net debt) at Mar 2026.
Questions
What is Prestige Consumer Healthcare Inc.'s P/E ratio?
Investors pay $13.9 for every $1 of Prestige Consumer Healthcare Inc.'s yearly profit, lower than 76% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Prestige Consumer Healthcare Inc.: $2.3 B ÷ $1.9 B (30 Jun 2026) = 1.2.
What is Prestige Consumer Healthcare Inc.'s return on equity?
Prestige Consumer Healthcare Inc. earned 9.1% on its shareholders' money over the last year, higher than 83% of Healthcare companies in United States.
How much does Prestige Consumer Healthcare Inc. owe compared with what it owns?
Prestige Consumer Healthcare Inc. owes $0.58 for every $1 it owns (moderate), higher than 62% of Healthcare companies in United States.
Does Prestige Consumer Healthcare Inc. pay a dividend?
No. Prestige Consumer Healthcare Inc. does not currently pay a dividend.
Is Prestige Consumer Healthcare Inc.'s revenue growing?
Revenue fell 4% in the year to Mar 2026, and shrank 1% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.